See also this year's filing and all EDGAR filings for this company.
PDF Report 0001724521_2023_Arcus_Biosciences_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001724521, Arcus Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,067,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 35,000,000 |
| 3 | remainder_Assets | 243,000,000 |
| 4 | LiabilitiesCurrent | 193,000,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 104,000,000 |
| 9 | ResearchAndDevelopmentExpense | 288,000,000 |
| 10 | remainder_Expenses | 1,000,000 |
| 11 | remainder_Revenues | 112,000,000 |
| 12 | remainder_NetIncome | 14,000,000 |
| 13 | remainder_ComprehensiveNetIncome | -6,000,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,345,000,000 |
| 1 | Liabilities | 193,000,000 |
| 2 | Expenses | 393,000,000 |
| 3 | Revenues | 112,000,000 |
| 4 | StockholdersEquity | 1,152,000,000 |
| 5 | NetIncome | -267,000,000 |
| 6 | ComprehensiveNetIncome | -270,000,000 |
| 7 | BaseVar | 1,031,500,000 |
| 8 | EconomicCapitalRatio | 2.23 |